Authors:
HUYSMANS K
LINS RL
DAELEMANS R
ZACHEE P
DEBROE ME
Citation: K. Huysmans et al., HYPERTENSION AND ACCELERATED ATHEROSCLEROSIS IN END-STAGE RENAL-DISEASE, JN. Journal of nephrology, 11(4), 1998, pp. 185-195
Authors:
DEROUBAIX X
LINS RL
LENS S
ALLEMON A
JEANBAPTISTE B
POLI G
ACERBI D
STOCKIS A
VENTURA P
Citation: X. Deroubaix et al., SINGLE-DOSE PHARMACOKINETICS OF MANIDIPINE IN HEPATIC IMPAIRED PATIENTS AND HEALTHY CONTROLS, International journal of clinical pharmacology and therapeutics, 36(7), 1998, pp. 386-391
Authors:
SCHWARTZ JI
DESMET M
LARSON P
LINS RL
LENS S
VERBESSELT R
EBEL DL
GERTZ BJ
Citation: Ji. Schwartz et al., INFLUENCE OF THE SELECTIVE CYCLOOXYGENASE-2 INHIBITOR, MK-0966 [MK], ON DIGOXIN [DG] SERUM CONCENTRATIONS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 529-529
Authors:
SNOECK E
PIOTROVSKIJ V
JACQMIN P
LINS RL
VANPEER A
DANHOF M
WOESTENBORGHS R
VANGOOL R
DUPONT AG
HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 57-63
Authors:
KAMPER AM
LINS RL
ZACHEE P
VANBERGEN S
HOSTEN S
DAELEMANS R
Citation: Am. Kamper et al., SAFETY OF COMBINING TICLOPIDINE WITH NADROPARIN IN THE ROUTINE TREATMENT OF CHRONIC-HEMODIALYSIS PATIENTS, Nephron, 77(4), 1997, pp. 484-485
Authors:
DEROUBAIX X
LINS RL
LENS S
DEMBLON C
JEANBAPTISTE B
POELAERT D
STOCKIS A
Citation: X. Deroubaix et al., COMPARATIVE BIOAVAILABILITY OF A METOPROLOL CONTROLLED-RELEASE FORMULATION AND A BISOPROLOL NORMAL RELEASE TABLET AFTER SINGLE ORAL DOSE ADMINISTRATION IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 34(2), 1996, pp. 61-70
Authors:
HAMDY NAT
KANIS JA
BENETON MNC
BROWN CB
JUTTMANN JR
JORDANS JGM
JOSSE S
MEYRIER A
LINS RL
FAIREY IT
Citation: Nat. Hamdy et al., EFFECT OF ALFACALCIDOL ON NATURAL COURSE OF RENAL BONE-DISEASE IN MILD-TO-MODERATE RENAL-FAILURE, BMJ. British medical journal, 310(6976), 1995, pp. 358-363
Citation: Mml. Janssens et Rl. Lins, ASTEMIZOLE-D CAUSES LESS SLEEP IMPAIRMENT THAN LORATADINE-D, Journal of international medical research, 23(3), 1995, pp. 167-174
Authors:
ELSEVIERS MM
DESCHEPPER A
CORTHOUTS R
BOSMANS JL
COSYN L
LINS RL
LORNOY W
MATTHYS E
ROOSE R
VANCAESBROECK D
WALLER I
HORACKOVA M
SCHWARZ A
SVRCEK P
BONUCCHI D
FRANEK E
MORLANS M
DEBROE ME
Citation: Mm. Elseviers et al., HIGH DIAGNOSTIC PERFORMANCE OF CT SCAN FOR ANALGESIC NEPHROPATHY IN PATIENTS WITH INCIPIENT TO SEVERE RENAL-FAILURE, Kidney international, 48(4), 1995, pp. 1316-1323
Authors:
ZACHEE P
FERRANT A
DAELEMANS R
GOOSSENS W
BOOGAERTS MA
LINS RL
Citation: P. Zachee et al., REDUCED GLUTATHIONE FOR THE TREATMENT OF ANEMIA DURING HEMODIALYSIS -A PRELIMINARY COMMUNICATION, Nephron, 71(3), 1995, pp. 343-349
Authors:
LAMBRECHT GLY
MALBRAIN MLNG
ZACHEE P
DAELEMANS R
LINS RL
Citation: Gly. Lambrecht et al., PORTAL-VEIN THROMBOSIS COMPLICATING PERITONITIS IN A PATIENT ON CHRONIC AMBULATORY PERITONEAL-DIALYSIS, Peritoneal dialysis international, 14(3), 1994, pp. 282-283
Authors:
MALBRAIN MLNG
LAMBRECHT GLY
DAELEMANS R
LINS RL
HERMANS P
ZACHEE P
Citation: Mlng. Malbrain et al., ACUTE-RENAL-FAILURE DUE TO BILATERAL LYMPHOMATOUS INFILTRATES - PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA (P-EN-NHL) OF THE KIDNEYS - DOES IT REALLY EXIST, Clinical nephrology, 42(3), 1994, pp. 163-169
Authors:
LINS RL
DECLERCQ I
HARTMANN M
HUBER R
BLIESATH H
LUHMANN R
WURST W
Citation: Rl. Lins et al., PHARMACOKINETICS OF THE PROTON PUMP INHIBITOR PANTOPRAZOLE IN PATIENTS WITH SEVERE RENAL IMPAIRMENT, Gastroenterology, 106(4), 1994, pp. 10000126-10000126
Citation: P. Zachee et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN DOSAGE REQUIREMENTS OVER THE YEARS, Nephrology, dialysis, transplantation, 8(4), 1993, pp. 374-375
Authors:
ZACHEE P
FERRANT A
DAELEMANS R
COOLEN L
GOOSSENS W
LINS RL
COUTTENYE M
DEBROE ME
BOOGAERTS MA
Citation: P. Zachee et al., OXIDATIVE INJURY TO ERYTHROCYTES, CELL RIGIDITY AND SPLENIC HEMOLYSISIN HEMODIALYZED PATIENTS BEFORE AND DURING ERYTHROPOIETIN TREATMENT, Nephron, 65(2), 1993, pp. 288-293